JAKARTA (Reuters) – Indonesia’s food and drug agency on Monday granted emergency use approval to a COVID-19 vaccine developed by China’s Sinovac Biotech, as it became the first country outside China to give the regulatory greenlight to the vaccine.
Interim data from a late-stage human test in Indonesia showed the shot was 65.3% effective, Penny K. Lukito, who heads the country’s food and drugs authority BPOM said.
(Reporting by Stanley Widianto and Beijing Newsroom; Editing by Ed Davies)
